Antimicrobial stewardship is often judged at the moment an antibiotic is selected: whether empirical coverage accords with guidance, whether the organism is susceptible, and whether therapy appears microbiologically appropriate. Yet treatment success and avoidable antimicrobial exposure are determined by a sequence of decisions that continues after initial prescribing. Diagnostic information becomes progressively more specific; pharmacokinetic and pharmacodynamic conditions may alter achieved exposure; source control can determine whether active antibiotics are sufficient; de-escalation becomes possible only when uncertainty falls; treatment duration must be actively reconsidered; and intravenous therapy may no longer be necessary once clinical and pharmacological conditions permit oral treatment. This For Debate article argues that stewardship should therefore be conceptualized as repeated evidence integration across the treatment course rather than as guideline-concordant antibiotic selection followed by passive continuation. The analysis distinguishes faster information from effective action, nominal susceptibility from exposure adequacy, antimicrobial activity from anatomical control, narrowing from indiscriminate spectrum reduction, shorter treatment from arbitrary stopping, and oral step-down from route substitution without eligibility assessment. A proposed adaptive stewardship decision architecture is developed in which diagnostic, pharmacological, anatomical, clinical and implementation information can reopen earlier treatment decisions as the patient's state changes. The framework is intentionally evidence-bounded. It does not imply that every patient should undergo every optimization step, that individual interventions have uniform clinical effects, or that an integrated architecture has been prospectively validated. Its purpose is to sharpen where stewardship decisions occur, why they remain conditional, and where failure to reassess can convert an initially reasonable antibiotic choice into progressively less appropriate treatment.
